Abstract A135: Addressing cancer health disparities through global oncology initiatives at a comprehensive cancer center
Authors: Fathi Parisa , Salinas Manisha , Albertie Monica , Odedina Folakemi 
Published: December 2023

Abstract
Background: The Mayo Clinic Comprehensive Cancer Center (MCCCC) is uniquely positioned to address cancer health disparities globally through the Community Outreach & Engagement (COE) Office and Program’s resources and partnerships in the areas of cancer research, education, and training. The goal of the COE Global Oncology Initiatives (GOI) is to lessen the cancer burden on patients globally by building global capacity through research, education, and training in MCCC impact regions. While MCCCC continues to build institutional relationships worldwide through the GOI, it has specifically increased research collaborations in Africa over the past 5 years. The purpose of this study is to synthesize and report the global oncology reach through scholarly output of collaborative efforts in ongoing research activities with partnering African countries. By analyzing and documenting research outputs within this area, we aim to better understand research priorities and needs, increase inclusivity of African populations, and improve potential avenues for impactful studies in global alliance networks. Methods: Publications were found by using key search terms and by using the map feature on Mayo Clinic’s Elsevier-hosted publication database to locate partner institutions throughout Africa. Only publications in the past 5 years, which included an African researcher as an author, and are relevant to cancer research were included. Duplicate publications were removed from the final dataset. Results: There are 86 unique MCCCC members collaborating with 11 different African countries (Algeria, Egypt, Ghana, Kenya, Morocco, Nigeria, South Africa, Tanzania, Tunisia, Uganda, and Zimbabwe). A total of 50 unique publications have been published, with an African country being represented 72 times. The majority of MCCCC global oncology work is with researchers in Sub-Saharan nations (n=43). Egypt, however, has the largest single country representation (n=22), followed by South Africa (n=14) and Nigeria (n=13). 164 unique African researchers across 133 different institutions have worked with MCCCC members. Prostate and liver cancer were the most represented cancers at 6 instances, respectively. Discussion: Overall, 86 MCCCC members are involved in global research that address cancer health disparities through equal partnership with African researchers, which has resulted in multiple research output. Some of the publications were led by global consortia or cohort studies. These collaborations have been mutually beneficial for MCCCC members and African investigators, elevating cancer research in Africa. This includes increased research scholarship, extramural funding for cancer research in Africa, opening of more clinical trials across the continent, and increase in cancer biomedical workforce. Global research, especially one that is inclusive of the African populations, will foster the understanding of the genetic architecture of cancer, and help shape cancer care and control for Africans and people of African ancestry.
Citation Format: Parisa Fathi, Manisha Salinas, Monica Albertie, Folakemi Odedina. Addressing cancer health disparities through global oncology initiatives at a comprehensive cancer center [abstract]. In: Proceedings of the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2023 Sep 29-Oct 2;Orlando, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2023;32(12 Suppl):Abstract nr A135.